Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Schering Claritin, SB Relafen patent extensions could be pursued by Sen. Thompson.

Executive Summary

SCHERING CLARITIN, SB RELAFEN PATENT EXTENSIONS COULD BE PURSUED BY SEN. THOMPSON during floor debate on Sen. Hatch's (R-Utah) patent office reform bill (S 507), Thompson (R-Tenn.) indicated during a Judiciary Committee mark-up of the bill May 22. "I strongly believe that action needs to be taken in the near future on the subject of pipeline drugs and that action is necessary with or without comprehensive review of Hatch/Waxman," Thompson said. Hatch's omnibus patent bill was reported out of the committee by voice vote at the mark-up .



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts